213 related articles for article (PubMed ID: 18626536)
1. The survival analysis of beta thalassemia major patients in South East of Iran.
Roudbari M; Soltani-Rad M; Roudbari S
Saudi Med J; 2008 Jul; 29(7):1031-5. PubMed ID: 18626536
[TBL] [Abstract][Full Text] [Related]
2. RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran.
Karimi M; Nikrooz P; Kashef S; Jamalian N; Davatolhagh Z
Int J Lab Hematol; 2007 Oct; 29(5):321-6. PubMed ID: 17824911
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece.
Ladis V; Chouliaras G; Berdousi H; Kanavakis E; Kattamis C
Ann N Y Acad Sci; 2005; 1054():445-50. PubMed ID: 16339695
[TBL] [Abstract][Full Text] [Related]
4. Survival of thalassemic patients referred to the Boo Ali Sina Teaching Hospital, Sari, Iran.
Kosaryan M; Vahidshahi K; Karami H; Forootan MA; Ahangari M
Hemoglobin; 2007; 31(4):453-62. PubMed ID: 17994379
[TBL] [Abstract][Full Text] [Related]
5. Survival, mortality, and complications in patients with beta-thalassemia major in northern Taiwan.
Chern JP; Su S; Lin KH; Chang SH; Lu MY; Jou ST; Lin DT; Ho WL; Lin KS
Pediatr Blood Cancer; 2007 May; 48(5):550-4. PubMed ID: 16972241
[TBL] [Abstract][Full Text] [Related]
6. Complications of β-thalassemia intermedia in Iran during 1996-2010 (single-center study).
Rafsanjani KA; Mafi N; Tafreshi RI
Pediatr Hematol Oncol; 2011 Sep; 28(6):497-508. PubMed ID: 21728720
[TBL] [Abstract][Full Text] [Related]
7. Malignancies in patients with beta-thalassemia major and beta-thalassemia intermedia: a multicenter study in Iran.
Karimi M; Giti R; Haghpanah S; Azarkeivan A; Hoofar H; Eslami M
Pediatr Blood Cancer; 2009 Dec; 53(6):1064-7. PubMed ID: 19533641
[TBL] [Abstract][Full Text] [Related]
8. Survival in medically treated patients with homozygous beta-thalassemia.
Olivieri NF; Nathan DG; MacMillan JH; Wayne AS; Liu PP; McGee A; Martin M; Koren G; Cohen AR
N Engl J Med; 1994 Sep; 331(9):574-8. PubMed ID: 8047081
[TBL] [Abstract][Full Text] [Related]
9. The survival analysis of beta thalassemia major patients in the South East of Iran.
Al-Mendalawi MD
Saudi Med J; 2008 Nov; 29(11):1680; author reply 1680-1. PubMed ID: 18998028
[No Abstract] [Full Text] [Related]
10. Red cell immunization in beta thalassaemia major.
Bhatti FA; Salamat N; Nadeem A; Shabbir N
J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
[TBL] [Abstract][Full Text] [Related]
11. Relationship between elevated liver enzyme with iron overload and viral hepatitis in thalassemia major patients in Northern Iran.
Ameli M; Besharati S; Nemati K; Zamani F
Saudi Med J; 2008 Nov; 29(11):1611-5. PubMed ID: 18998011
[TBL] [Abstract][Full Text] [Related]
12. Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia.
Bradai M; Pissard S; Abad MT; Dechartres A; Ribeil JA; Landais P; de Montalembert M
Transfusion; 2007 Oct; 47(10):1830-6. PubMed ID: 17880608
[TBL] [Abstract][Full Text] [Related]
13. Survival and complications in thalassemia.
Borgna-Pignatti C; Cappellini MD; De Stefano P; Del Vecchio GC; Forni GL; Gamberini MR; Ghilardi R; Origa R; Piga A; Romeo MA; Zhao H; Cnaan A
Ann N Y Acad Sci; 2005; 1054():40-7. PubMed ID: 16339650
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in bone marrow transplantation for beta thalassemia major: experiences from Iran.
Ghavamzadeh A; Nasseri P; Eshraghian MR; Jahani M; Baybordi I; Nateghi J; Khodabandeh A; Sadjadi AR; Mohyeddin M; Khademi Y
Bone Marrow Transplant; 1998 Dec; 22(12):1167-9. PubMed ID: 9894719
[TBL] [Abstract][Full Text] [Related]
15. Disease knowledge and treatment adherence among patients with thalassemia major and their mothers in Taiwan.
Lee YL; Lin DT; Tsai SF
J Clin Nurs; 2009 Feb; 18(4):529-38. PubMed ID: 19192002
[TBL] [Abstract][Full Text] [Related]
16. Endocrinopathies in patients with transfusion-dependent beta-thalassemia.
Mehrvar A; Azarkeivan A; Faranoush M; Mehrvar N; Saberinedjad J; Ghorbani R; Vossough P
Pediatr Hematol Oncol; 2008; 25(3):187-94. PubMed ID: 18432501
[TBL] [Abstract][Full Text] [Related]
17. Analysis of intelligence quotient in patients with homozygous beta-thalassemia.
Karimi M; Yarmohammadi H; Cappellini MD
Saudi Med J; 2006 Jul; 27(7):982-5. PubMed ID: 16830015
[TBL] [Abstract][Full Text] [Related]
18. Morbidities and mortality in transfusion-dependent Beta-thalassemia patients (single-center experience).
Mokhtar GM; Gadallah M; El Sherif NH; Ali HT
Pediatr Hematol Oncol; 2013 Mar; 30(2):93-103. PubMed ID: 23301991
[TBL] [Abstract][Full Text] [Related]
19. Growth velocity in transfusion dependent prepubertal thalassemia patients: results from a thalassemia center in Malaysia.
Hamidah A; Arini MI; Zarina AL; Zulkifli SZ; Jamal R
Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):900-5. PubMed ID: 19058587
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of HCV antibody among patients with beta-thalassemia major in Amirkola Thalassemia Center, Iran.
Tamaddoni A; Mohammadzadeh I; Ziaei O
Iran J Allergy Asthma Immunol; 2007 Mar; 6(1):41. PubMed ID: 17303929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
